Research News
View articles by month and year
-
Cymbalta Helps Ease Neuropathy Caused by Chemo
A study has found that most people with peripheral neuropathy got some relief from the antidepressant medicine Cymbalta.
-
T-DM1 Works Better on Advanced-Stage, HER2-Positive Cancer Than Standard Meds
A study found that women diagnosed with advanced-stage, HER2-positive breast cancer that had stopped responding to a standard regimen lived longer without the cancer growing when they got the experimental medicine T-DM1 compared to women who got a different regimen.
-
New Doxorubicin Formula May Be Safer for Heart Than Traditional Formulas
A small study suggests that a new formulation of the chemotherapy medicine doxorubicin may be safer for the heart than traditional formulations.
-
Afinitor Before Surgery Doesn’t Help Treat HER2-Negative Breast Cancer
Research has found that adding Afinitor to paclitaxel didn't improve the response to neoadjuvant treatment with paclitaxel in women diagnosed with advanced-stage, HER2-negative breast cancer.
-
Giving Chemo and Radiation Therapy at Same Time Offers Same Benefits as Sequential Timing
In a study of women who'd been diagnosed with early breast cancer, local recurrence happened 35% less often in those who were treated with chemotherapy and radiation at the same time rather than sequentially (one after the other).
-
Experimental T-DM1 May Help Treat Advanced-Stage, HER2-Positive Disease
In a preliminary study, women with HER2-positive locally advanced or metastatic breast cancer treated with the targeted therapy T-DM1 lived longer without the cancer showing signs of progression compared to similar women who received a standard treatment combination of Herceptin (chemical name: trastuzumab) and Taxotere (chemical name: docetaxel).
-
“Personality” of Cancer Affects Recurrence Risk After Lumpectomy, Not When Chemo is Given
A study has found that cancer characteristics, not the timing of chemotherapy, affect the risk of recurrence in women diagnosed with early-stage breast cancer who had lumpectomy.
-
Trelstar Reduces Risk of Chemo-Induced Menopause
Giving the medicine triptorelin during chemotherapy for breast cancer may hold off chemotherapy-induced menopause.
-
Experimental Genomic Test May Help Determine Need for Chemo Before Surgery
An experimental genomic test may help doctors figure out if invasive HER2-negative breast cancer will respond to chemotherapy before surgery.
-
FDA Approves Generic Taxotere
The FDA has approved a generic form of Taxotere, which may lower treatment costs.
